AccurKardiaās AK-AVS Joins FDA TAP Program for AI Heart Screening
NEW YORK, June 16, 2026 AccurKardia announced that its AK-AVS⢠aortic valve stenosis screening software has been accepted into...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
NEW YORK, June 16, 2026 AccurKardia announced that its AK-AVS⢠aortic valve stenosis screening software has been accepted into...
